EPA Plans to Ditch Linchpin Climate Policy, Washington Post Says
The so-called ' endangerment finding,' published in 2009, has been the legal basis of a wide range of climate rules under the Clean Air Act. A draft proposal to formally abandon the policy is being considered by the EPA, though is still subject to change, the newspaper reported, citing two sources familiar with the details which it didn't name.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Fact or Fiction: Noncolorectal Gastrointestinal Cancer
Noncolorectal gastrointestinal (GI) cancers present unique challenges in diagnosis, management, and prognosis. Knowledge of risk factors, presenting features, and contemporary treatment guidelines is essential for timely recognition and effective care. Pancreatic cancer is primarily diagnosed among older adults. Nearly 90% of cases occur in individuals older than 55 years. Besides age, additional risk factors include smoking, diabetes, and obesity. Learn more about pancreatic cancer epidemiology. Due to nonspecific symptoms, most patients with gastric cancer present with advanced disease, contributing to a worldwide 5-year survival rate of approximately 10%. Further, a study of patients with gastric cancer younger than 50 years found that 87% were symptomatic at diagnosis. Learn more about gastric cancer presentation. The incidence of esophageal adenocarcinoma in the US rose dramatically from the 1970s until 2006, then leveled off, and it is also continuing to increase in other countries due to certain lifestyle factors. Surveillance, Epidemiology, and End Results data from 2012-2022 show that incidence rates have remained steady at about 5.0-5.1 per 100,000 in males and 0.6-0.8 per 100,000 in females. Although rising obesity and metabolic syndrome rates probably contributed to prior increases, this does not fully explain the subsequent plateau. Learn more about esophageal cancer epidemiology. Current National Comprehensive Cancer Network (NCCN) guidelines recommend adjuvant chemotherapy after resection of biliary tract cancer; capecitabine is the preferred regimen. American Society of Clinical Oncology guidelines also recommend that patients should undergo adjuvant chemotherapy with capecitabine for 6 months after biliary tract cancer resection. Adjuvant chemotherapy or chemoradiation has been shown to improve survival in patients with biliary tract cancer, with the benefit being particularly notable among those with lymph node involvement. Learn more about biliary tract cancer treatment protocols. Studies have shown that the combination of an immune checkpoint inhibitor (ICI) and a vascular endothelial growth factor (VEGF) inhibitor, rather than a TKI plus cytotoxic chemotherapy, is associated with favorable survival outcomes and has recently become the standard initial treatment for advanced HCC. Although TKI may still be used as systemic therapy, c urrent NCCN guidelines recommend atezolizumab (an ICI) plus bevacizumab (a VEGF inhibitor) as one of the preferred initial systemic therapy regimens for advanced HCC; tremelimumab-actl plus durvalumab (both monoclonal antibody therapies) is another preferred initial option. Learn more about HCC treatments. Editor's Note: This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication.
Bloomberg
an hour ago
- Bloomberg
Sarepta Needs to Show FDA Elevidys Won't Cause More Deaths
The Food and Drug Administration won't sign off on Sarepta Therapeutics Inc. bringing its controversial gene therapy back to the market until the company can persuade US regulators that it won't cause more deaths, according to an official familiar with the situation. The FDA has not seen a convincing explanation as to why Sarepta's gene therapy for Duchenne muscular dystrophy, Elevidys, was tied to two fatal cases of liver failure, the official said, and there may be no single, easily addressable problem the company can quickly fix. A third fatal case of liver failure that occurred during a trial of a separate but similar Sarepta gene therapy is unquestionably relevant information to the safety of Elevidys, said the official, who declined to be identified because the agency's deliberations are private.
Fox News
2 hours ago
- Fox News
BREAKING: Senator Roger Marshall Reacts to WSJ Report That Trump Was Told He Is in the Epstein Files
Senator Roger Marshall, MD (R-KS), joined The Guy Benson Show today to react live to the breaking Wall Street Journal report that Donald Trump was notified in May of being named in the Epstein files, but the story also emphasizes that simply being listed among hundreds of names does not equate to evidence of wrongdoing. Marshall blasted Democrats for seizing on stories like this as a distraction from their lack of substantive policy, even attempting to repeal Trump's newly passed 'Big Beautiful Law,' which he warned would harm everyday Americans. Sen. Marshall also pushed back on the Left's false claims suggesting the 'Big Beautiful Law' would strip healthcare coverage from vulnerable populations who are unable to work. Listen to the full interview below! Listen to the full interview below: Listen to the full podcast below:
